16.45 M
About Drugs Made In America Acquisition Corp.
Sector
Industry
CEO
Lynn Stockwell
Headquarters
Fort Lauderdale
FIGI
BBG01RQ5FQV1
Drugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Drugs Made In America Acquisition Corp. stocks are traded under the ticker DMAA.
DMAA stock has fallen by −0.20% compared to the previous week, the month change is a −0.20% fall, over the last year Drugs Made In America Acquisition Corp. has showed a −0.10% decrease.
Yes, you can track Drugs Made In America Acquisition Corp. financials in yearly and quarterly reports right on TradingView.
DMAA net income for the last quarter is −144.93 K USD, while the quarter before that showed −54.93 K USD of net income which accounts for −163.84% change. Track more Drugs Made In America Acquisition Corp. financial stats to get the full picture.
No, DMAA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DMAA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Drugs Made In America Acquisition Corp. stock right from TradingView charts — choose your broker and connect to your account.